← back to search

Jonathan P. Richardson

King's College London · GB
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Antifungal resistance and susceptibility, Fungal Infections and Studies, Asthma and respiratory diseases, and Antimicrobial Peptides and Activities.
h-index
36
citations
5,178
works
125
NIH funding
primary concept
email

Recent publications

Toll-like receptor 4 and CD11b expressed on microglia coordinate eradication of Candida albicans cerebral mycosis
Cell Reports 2023cited by 57position: middledoi
Candidalysins Are a New Family of Cytolytic Fungal Peptide Toxins
mBio 2022cited by 69position: firstdoi
Candida albicans: A Major Fungal Pathogen of Humans
Pathogens 2022cited by 40position: firstdoi
Receptor-kinase EGFR-MAPK adaptor proteins mediate the epithelial response to Candida albicans via the cytolytic peptide toxin, candidalysin
Journal of Biological Chemistry 2022cited by 21position: middledoi
<i>Candida albicans</i> biofilms and polymicrobial interactions
Critical Reviews in Microbiology 2021cited by 245position: lastdoi
Fungal Toxins and Host Immune Responses
Frontiers in Microbiology 2021cited by 98position: lastdoi
A variant ECE1 allele contributes to reduced pathogenicity of Candida albicans during vulvovaginal candidiasis
PLoS Pathogens 2021cited by 72position: middledoi
Candidalysin triggers epithelial cellular stresses that induce necrotic death
Cellular Microbiology 2021cited by 49position: middledoi
Role for IL-1 Family Cytokines in Fungal Infections
Frontiers in Microbiology 2021cited by 47position: middledoi
<i>Candida albicans</i> and candidalysin in inflammatory disorders and cancer
Immunology 2020cited by 71position: middledoi
Candidalysin Is a Potent Trigger of Alarmin and Antimicrobial Peptide Release in Epithelial Cells
Cells 2020cited by 53position: middledoi
Programmed Cell Death: Central Player in Fungal Infections
Trends in Cell Biology 2020cited by 47position: lastdoi
Candidalysin activates innate epithelial immune responses via epidermal growth factor receptor
Nature Communications 2019cited by 175position: middledoi
Candida albicans Interactions with Mucosal Surfaces during Health and Disease
Pathogens 2019cited by 102position: lastdoi
Candida albicans-Induced Epithelial Damage Mediates Translocation through Intestinal Barriers
mBio 2018cited by 192position: middledoi
Processing of <i>Candida albicans</i> Ece1p Is Critical for Candidalysin Maturation and Fungal Virulence
mBio 2018cited by 99position: firstdoi
IL-36 and IL-1/IL-17 Drive Immunity to Oral Candidiasis via Parallel Mechanisms
The Journal of Immunology 2018cited by 98position: middledoi
Candida–Epithelial Interactions
Journal of Fungi 2018cited by 94position: firstdoi
Candida innate immunity at the mucosa
Seminars in Cell and Developmental Biology 2018cited by 71position: firstdoi
Oral epithelial cells orchestrate innate type 17 responses to <i>Candida albicans</i> through the virulence factor candidalysin
Science Immunology 2017cited by 204position: middledoi
Candidalysin Drives Epithelial Signaling, Neutrophil Recruitment, and Immunopathology at the Vaginal Mucosa
Infection and Immunity 2017cited by 179position: firstdoi
Candidalysin is a fungal peptide toxin critical for mucosal infection
Nature 2016cited by 890position: middledoi
IL-17 Receptor Signaling in Oral Epithelial Cells Is Critical for Protection against Oropharyngeal Candidiasis
Cell Host & Microbe 2016cited by 179position: middledoi
Epithelial discrimination of commensal and pathogenic <i>Candida albicans</i>
Oral Diseases 2016cited by 38position: middledoi
Adaptive immune responses to<i>Candida albicans</i>infection
Virulence 2015cited by 197position: firstdoi
<i>Candida albicans-</i>epithelial interactions and pathogenicity mechanisms: scratching the surface
Virulence 2015cited by 172position: middledoi
Candida albicans Pathogenicity and Epithelial Immunity
PLoS Pathogens 2014cited by 117position: middledoi
Protection Against Epithelial Damage During Candida albicans Infection Is Mediated by PI3K/Akt and Mammalian Target of Rapamycin Signaling
The Journal of Infectious Diseases 2013cited by 106position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Julian R. Naglik · King's College London25 papers (2013–2023)David L. Moyes · King's College London14 papers (2013–2022)Jemima Ho · King's College London12 papers (2017–2022) · 11 papers (2017–2023)Nicole O. Ponde · University of Pittsburgh7 papers (2018–2022)Sarah L. Gaffen · University of Pittsburgh6 papers (2016–2022)Nessim Kichik · King's College London6 papers (2018–2023)Mariana Blagojevic · King's College London4 papers (2018–2021)Akash Verma · North Carolina State University4 papers (2016–2018) · 4 papers (2016–2018)Giorgio Camilli · AstraZeneca (Spain)4 papers (2020–2021)Don N. Wickramasinghe · King's College London3 papers (2020–2022)Léa Lortal · University of California, San Francisco3 papers (2021–2023)Olivia W. Hepworth · Harvard University3 papers (2018–2022) · 3 papers (2018–2022)Spyridoula-Angeliki Nikou · University College London3 papers (2019–2020)James S. Griffiths · King's College London3 papers (2020–2023)Rhys Brown · King's College London3 papers (2019–2022)Brian M. Peters · University of Tennessee Health Science Center2 papers (2017–2021) · 2 papers (2018–2023)